Mill Creek Capital Advisors, LLC

Position in PGEN — Precigen, Inc.

CIK 1964962 Conshohocken, PA

Position in PGEN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$581,080

-$45,920 QoQ

Shares Held

150,150

+0.1% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mill Creek Capital Advisors, LLC holds $2,260,246 across 4 Biotechnology names. PGEN ranks #3 (25.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADAG	Adagene Inc.	199,610	$782,471
2	SRRK	Scholar Rock Holding Corp	12,664	$622,562
3	PGEN	Precigen, Inc. This page	150,150	$581,080
4	CNTX	Context Therapeutics Inc.	104,631	$274,133

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$581,080	150,150	+0.1%	Shares	Sole	2026-05-14
2025-12-31	$627,000	150,000	0.0%	Shares	Sole	2026-02-13
2025-09-30	$493,500	150,000	-41.2%	Shares	Sole	2025-11-12
2025-06-30	$362,100	255,000	0.0%	Shares	Sole	2025-08-11
2025-03-31	$379,950	255,000	+131.8%	Shares	Sole	2025-05-13
2024-12-31	$123,200	110,000	0.0%	Shares	Sole	2025-01-29
2024-09-30	$104,500	110,000	—	Shares	Sole	2024-11-06
No filing history on record for this holder in this stock.